In March 2025, the company introduced new plans to get a direct-to-customer offering of its Wegovy weight loss drug. The company established a whole new pharmacy, known as NovoCare, which would charge clients $499 per month for use of the drug, below 50 % the expense of the drug by means of other pharmaceutical distribution networks.[fifty three]Pr